Malignant conversion of mouse skin tumours is increased by tumour initiators and unaffected by tumour promoters (original) (raw)

Nature volume 304, pages 67–69 (1983)Cite this article

Abstract

Multi-stage carcinogenesis (initiation–promotion) was first demonstrated in mouse skin1,2. The first stage, initiation, is accomplished by a low dose of carcinogen that causes no tumours. Promotion by repeated treatment of initiated mice with certain non-carcinogenic hyperplastic agents results in the rapid production of numerous benign papillomas, a few of which progress to squamous cell carcinomas. Although this model system produces mostly benign tumours, many of the concepts concerning carcinogenesis in epithelial tissues have been derived from mouse skin studies. The permanent change in growth potential accomplished by tumour initiators is generally considered to be a mutagenic event3; cell selection and clonal expansion of initiated cells may be involved in promotion4. In initiation–promotion experiments, more than 90% of the squamous cell carcinomas develop from papillomas5,6, but the conversion rate is low. The factors necessary for this conversion of benign to malignant tumours have not been defined but tumour promoters have been assumed to be involved. However, we report here that the tumour promoter 12-_O_-tetradecanoyl-phorbol-13-acetate (TPA) is ineffective in the conversion of papillomas to carcinomas whereas three initiators, urethane, N-methyl-_N′_-nitro-_N_-nitrosoguanidine ((MNNG) and 4-nitroquinoline-_N_-oxide (4-NQO) are effective. This suggests that malignant conversion may result from a further genetic change in papilloma cells and that the ineffectiveness of TPA may be due to its inactivity as a mutagen.

This is a preview of subscription content, access via your institution

Access options

Subscribe to this journal

Receive 51 print issues and online access

$199.00 per year

only $3.90 per issue

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

Similar content being viewed by others

References

  1. Mottram, J. C. J. Path. Bact. 56, 181–187 (1944).
    Article CAS Google Scholar
  2. Berenblum, I. & Shubik, P. Br. J. Cancer 1, 383–391 (1947).
    Article CAS Google Scholar
  3. Miller, E. C. & Miller, J. A. Cancer 47, 2327–2345 (1981).
    Article CAS Google Scholar
  4. Yuspa, S. H. Ben, T. Hennings, H. & Lichti, U. Cancer Res. 42, 2344–2349 (1982).
    CAS PubMed Google Scholar
  5. Shubik, P., Baserga, R. & Ritchie, A. C. Br. J. Cancer 7, 342–351 (1953).
    Article CAS Google Scholar
  6. Burns, F. J., Vanderlaan, M., Snyder, E. & Albert, R. E. in Carcinogenesis Vol. 2 (eds Slaga, T. J., Sivak, A. & Boutwell, R. K.) 91–96 (Raven, New York, 1978).
    Google Scholar
  7. Hennings, H. et al. Cancer Res. 41, 773–779 (1981).
    CAS PubMed Google Scholar
  8. Hennings, H., Bowden, G. T. & Boutwell, R. K. Cancer Res. 29, 1773–1780 (1969).
    CAS PubMed Google Scholar
  9. Saffiotti, U. & Shubik, P. J. natn. Cancer Inst. 16, 961–969 (1956).
    CAS Google Scholar
  10. Shubik, P. Cancer Res. 10, 713–717 (1950).
    CAS PubMed Google Scholar
  11. Scribner, J. D. & Scribner, N. K. in Carcinogenesis Vol. 7 (eds Hecker, E., Fusenig, N. E., Kunz, W., Marks, F. & Thielmann, H. W.) 13–18 (Raven, New York, 1982).
    Google Scholar
  12. Verma, A. K. & Boutwell, R. K. Carcinogenesis 1, 271–276 (1980).
    Article CAS Google Scholar
  13. Colburn, N. H. in Neoplastic Transformation in Differentiated Epithelial Cell Systems In Vitro (eds Franks, L. M. & Wigley, C. B.) 113–133 (Academic, New York, 1979).
    Google Scholar
  14. Roe, F. J. C., Carter, C. L., Mitchley, B. C. V., Peto, R. & Hecker, E. Int. J. Cancer 9, 264–273 (1972).
    Article CAS Google Scholar
  15. Moolgavkar, S. H. & Knudson, A. G. Jr J. natn. Cancer Inst. 66, 1037–1052 (1981).
    Article CAS Google Scholar
  16. Potter, V. R. Carcinogenesis 2, 1375–1379 (1981).
    Article CAS Google Scholar
  17. Yuspa, S. H., Hennings, H. & Lichti, U. J. supramolec. Struct. 17, 245–257 (1981).
    CAS Google Scholar
  18. Peto, R. et al. IARC Monogr. on the Evaluation of the Carcinogenic Risk of Chemicals to Humans Suppl. 2, 311–426 (1980).
  19. Gart, J. J., Chu, K. C. & Tarone, R. E. J. natn. Cancer Inst. 62, 957–974 (1979).
    CAS Google Scholar

Download references

Author information

Authors and Affiliations

  1. In Vitro Pathogenesis Section, Laboratory of Cellular Carcinogenesis and Tumor Promotion, National Cancer Institute, Bethesda, Maryland, 20205, USA
    Henry Hennings & Stuart H. Yuspa
  2. Microbiological Associates, Bethesda, Maryland, 20016, USA
    Robert Shores, Martin L. Wenk & Edwin F. Spangler
  3. Mathematical Statistics and Applied Mathematics Section, Biometry branch, National Cancer Institute, Bethesda, Maryland, 20205, USA
    Robert Tarone

Authors

  1. Henry Hennings
    You can also search for this author inPubMed Google Scholar
  2. Robert Shores
    You can also search for this author inPubMed Google Scholar
  3. Martin L. Wenk
    You can also search for this author inPubMed Google Scholar
  4. Edwin F. Spangler
    You can also search for this author inPubMed Google Scholar
  5. Robert Tarone
    You can also search for this author inPubMed Google Scholar
  6. Stuart H. Yuspa
    You can also search for this author inPubMed Google Scholar

Rights and permissions

About this article

Cite this article

Hennings, H., Shores, R., Wenk, M. et al. Malignant conversion of mouse skin tumours is increased by tumour initiators and unaffected by tumour promoters.Nature 304, 67–69 (1983). https://doi.org/10.1038/304067a0

Download citation